Mapping Gene Associations in Human Mitochondria using Clinical Disease Phenotypes

Nuclear genes encode most mitochondrial proteins, and their mutations cause diverse and debilitating clinical disorders. To date, 1,200 of these mitochondrial genes have been recorded, while no standardized catalog exists of the associated clinical phenotypes. Such a catalog would be useful to develop methods to analyze human phenotypic data, to determine genotype-phenotype relations among many genes and diseases, and to support the clinical diagnosis of mitochondrial disorders. Here we establish a clinical phenotype catalog of 174 mitochondrial disease genes and study associations of diseases and genes. Phenotypic features such as clinical signs and symptoms were manually annotated from full-text medical articles and classified based on the hierarchical MeSH ontology. This classification of phenotypic features of each gene allowed for the comparison of diseases between different genes. In turn, we were then able to measure the phenotypic associations of disease genes for which we calculated a quantitative value that is based on their shared phenotypic features. The results showed that genes sharing more similar phenotypes have a stronger tendency for functional interactions, proving the usefulness of phenotype similarity values in disease gene network analysis. We then constructed a functional network of mitochondrial genes and discovered a higher connectivity for non-disease than for disease genes, and a tendency of disease genes to interact with each other. Utilizing these differences, we propose 168 candidate genes that resemble the characteristic interaction patterns of mitochondrial disease genes. Through their network associations, the candidates are further prioritized for the study of specific disorders such as optic neuropathies and Parkinson disease. Most mitochondrial disease phenotypes involve several clinical categories including neurologic, metabolic, and gastrointestinal disorders, which might indicate the effects of gene defects within the mitochondrial system. The accompanying knowledgebase (http://www.mitophenome.org/) supports the study of clinical diseases and associated genes.

[1]  Ronald J A Wanders,et al.  2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase (MHBD) Deficiency: An X-linked Inborn Error of Isoleucine Metabolism that May Mimic a Mitochondrial Disease , 2005, Pediatric Research.

[2]  Bernhard O Palsson,et al.  Building the power house: recent advances in mitochondrial studies through proteomics and systems biology. , 2007, American journal of physiology. Cell physiology.

[3]  Ronald J A Wanders,et al.  Clinical variability in 3‐hydroxy‐2‐methylbutyryl‐coa dehydrogenase deficiency , 2002, Annals of neurology.

[4]  D. S. Parker,et al.  A collaborative knowledge base for cognitive phenomics , 2008, Molecular Psychiatry.

[5]  M A Holliday,et al.  Metabolic rate and organ size during growth from infancy to maturity and during late gastation and early infancy. , 1971, Pediatrics.

[6]  Sushant Kachhap,et al.  Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells , 2002, Molecular Cancer.

[7]  Sarah Calvo,et al.  MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion , 2006, Nature Genetics.

[8]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[9]  A. Barabasi,et al.  A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.

[10]  John D. Storey,et al.  Gene-expression variation within and among human populations. , 2007, American journal of human genetics.

[11]  D. Vitkup,et al.  Network properties of genes harboring inherited disease mutations , 2008, Proceedings of the National Academy of Sciences.

[12]  Ronald J. Moore,et al.  Integrative Analysis of the Mitochondrial Proteome in Yeast , 2004, PLoS biology.

[13]  Eric S. Lander,et al.  Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Ronald W. Davis,et al.  Systematic screen for human disease genes in yeast , 2002, Nature Genetics.

[15]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[16]  R Luft,et al.  The development of mitochondrial medicine. , 1995, Biochimica et biophysica acta.

[17]  Feng Liu,et al.  The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge , 2007, Nucleic Acids Res..

[18]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[19]  L. Biesecker,et al.  Mapping phenotypes to language: a proposal to organize and standardize the clinical descriptions of malformations , 2005, Clinical genetics.

[20]  Salvatore DiMauro,et al.  Nuclear power and mitochondrial disease , 1998, Nature Genetics.

[21]  Emily Singer,et al.  'Phenome' project set to pin down subgroups of autism , 2005, Nature Medicine.

[22]  P M Nadkarni,et al.  The challenges of recording phenotype in a generalizable and computable form , 2003, The Pharmacogenomics Journal.

[23]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[24]  Thomas Meitinger,et al.  MitoP2: the mitochondrial proteome database—now including mouse data , 2005, Nucleic Acids Res..

[25]  Holliday Ma,et al.  Metabolic rate and organ size during growth from infancy to maturity and during late gastation and early infancy. , 1971, Pediatrics.

[26]  Thomas G Schulze,et al.  The bipolar disorder phenome database: a resource for genetic studies. , 2007, The American journal of psychiatry.

[27]  A. Butte,et al.  Creation and implications of a phenome-genome network , 2006, Nature Biotechnology.

[28]  E. Holme,et al.  The incidence of mitochondrial encephalomyopathies in childhood: Clinical features and morphological, biochemical, and DNA abnormalities , 2001, Annals of neurology.

[29]  E. Bertini,et al.  Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. , 1998, American journal of human genetics.

[30]  Maria Bitner-Glindzicz,et al.  Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. , 2005, American journal of human genetics.

[31]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[32]  C. Sabatti,et al.  The Human Phenome Project , 2003, Nature Genetics.

[33]  C. Wijmenga,et al.  Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. , 2006, American journal of human genetics.

[34]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[35]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[36]  K. Petersen,et al.  Mitochondrial dysfunction and type 2 diabetes , 2005, Current diabetes reports.

[37]  G. Vriend,et al.  A text-mining analysis of the human phenome , 2006, European Journal of Human Genetics.

[38]  Sarah Calvo,et al.  Systematic identification of human mitochondrial disease genes through integrative genomics , 2006, Nature Genetics.

[39]  G. Enns.  The contribution of mitochondria to common disorders. , 2003, Molecular genetics and metabolism.

[40]  H. Brunner,et al.  From syndrome families to functional genomics , 2004, Nature Reviews Genetics.

[41]  Charis Eng,et al.  A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.

[42]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[43]  William Stanley,et al.  Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation , 2008, Cardiovascular research.

[44]  A. Galinier,et al.  Physiological diversity of mitochondrial oxidative phosphorylation. , 2006, American journal of physiology. Cell physiology.

[45]  D. Thorburn,et al.  Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.

[46]  Ronald W. Davis,et al.  Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.

[47]  J. Sass,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease , 2004, Brain and Development.

[48]  M. Vidal,et al.  Networking metabolites and diseases , 2008, Proceedings of the National Academy of Sciences.

[49]  D. Turnbull,et al.  Epidemiology and treatment of mitochondrial disorders. , 2001, American journal of medical genetics.